Clobetasol Propionate Spray Versus Vehicle Spray for the Management of Moderate to Severe Plaque Psoriasis of the Scalp
Sponsored by Galderma R&D
About this trial
Last updated 3 years ago
Study ID
US10118
Status
Completed
Type
Interventional
Phase
Phase 4
Placebo
No
Accepting
18+ Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 16 years ago
What is this trial about?
The primary objective of this study is to evaluate the safety and efficacy of clobetasol
propionate spray versus vehicle spray for the management of moderate to severe plaque
psoriasis of the scalp.
What are the participation requirements?
Inclusion Criteria
- Subjects with diagnosis of moderate to severe plaque psoriasis of the scalp
Exclusion Criteria
- Subjects who need systemic treatment for their body psoriasis
- Subjects who have surface area involvement too large (>20% Body Surface Area [BSA]) that would require more than 50 grams per week of study product